Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0495 USD | +4.21% | +16.47% | -19.51% |
02/05 | North American Morning Briefing : Stock Futures -2- | DJ |
25/04 | North American Morning Briefing : More Tech -2- | DJ |
Business Summary
Number of employees: 66
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Andrea Itano
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Duncan McHale
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/18/01 |
Chun Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 01/17/01 |
Mark W. Bodmer
CTO | Chief Tech/Sci/R&D Officer | 69 | 19/16/19 |
Mark D. Plinio
PRN | Corporate Officer/Principal | 57 | 14/21/14 |
Corporate Officer/Principal | - | - | |
Julie Carretero
HRO | Human Resources Officer | - | 14/20/14 |
Stuart Abel
LAW | General Counsel | - | 01/19/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | 21/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 18,930,960 | 18,905,228 ( 99.86 %) | 0 | 99.86 % |
Company contact information
Evelo Biosciences, Inc.
One Kendal Square, 600/700 Suite 7-201
02139, Cambridge
+
http://www.evelobio.comSector
1st Jan change | Capi. | |
---|---|---|
-19.51% | 940K | |
-1.65% | 103B | |
+6.75% | 101B | |
+5.71% | 23.07B | |
-12.60% | 22.23B | |
-9.70% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- EVLO Stock
- Company Evelo Biosciences, Inc.